Generic Name and Formulations:
Hydrocortisone acetate 10%; aerosol foam.
Indications for CORTIFOAM:
Adjunct in ulcerative proctitis in patients who cannot retain steroid enemas.
1 applicatorful rectally (80mg hydrocortisone) 1–2 times daily for 2–3 weeks. Then every other day. Discontinue if no improvement within 2–3 weeks.
Rectal obstruction. Abscess. Perforation. Peritonitis. Fresh intestinal anastomoses. Extensive fistulas and sinus tracts. Tuberculosis. Ocular herpes simplex. Psychosis. Peptic ulcer. Glomerulonephritis. Myasthenia gravis. Osteoporosis. Diverticulitis. Thrombophlebitis. Diabetes. Hyperthyroidism. Acute coronary disease. Hypertension. Limited cardiac reserve. Infections.
Postileorectostomy: not recommended. Exposure to varicella or vaccinia. Severe ulcerative disease. CHF. Renal or hepatic dysfunction. Monitor adrenal function and serum electrolytes. Avoid abrupt cessation. Vaccinations. Pregnancy (Cat.C). Nursing mothers.
May antagonize insulin or oral hypoglycemics, anticoagulants, aspirin. Hypokalemia with amphotericin B or diuretics. May be potentiated by macrolides, cyclosporine.
Hypertension, fluid retention, hypokalemia, adrenal suppression, cataracts, glaucoma, psychosis, dysmenorrhea, myopathy, neuropathy, thrombophlebitis, peptic ulcer, impaired wound healing, convulsions, local irritation (folliculitis, hypertrichosis, acne, hypopigmentation, macerations, dermal and epidermal atrophy, secondary infections, striae, miliaria).
Aerosol—15g (w. applicator)
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Antibiotic Use in Neonatal Settings in Need of Improvement
- Whole Genome Sequencing Use in Predicting TB Resistance
- Rapid Antimicrobial Susceptibility Testing on Urine Directly Accelerates Results
- Antibiotics May Be Beneficial in Children With Prolonged Wet Cough
- Emergency Department Overcrowding Associated With Delayed Antibiotics in Patients With Sepsis
- Success With DAA for Hepatitis C Prior to Stem Cell Transplant
- Shorter Antibiotic Course Noninferior for Gram-Negative Bacteremia
- Dolutegravir Plus Lamivudine Promising for HIV Maintenance Therapy
- Trial Results Affected by Heterogeneous CAP Inclusion Criteria
- Screening Blood Donations Mitigates Transfusion-Transmitted Babesiosis Risk